A single dose, randomised, double blind, double dummy, placebo controlled, 3-way crossover clinical study, comparing the onset of relief from methacholine-induced bronchoconstriction with CHF1535 100/6 μg NEXThaler versus CHF1535 100/6 μg pMDI in asthmatic patients.
Phase of Trial: Phase II
Latest Information Update: 10 Nov 2017
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Beclometasone/formoterol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Chiesi Farmaceutici SpA
- 06 Nov 2017 Status changed from recruiting to completed.
- 06 Apr 2017 New trial record